a substance being studied in the treatment of certain types of head and neck cancer. proxinium is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. it binds to epcam (a protein on the surface of epithelial cells and some types of cancer cells). also called anti-epcam-pseudomonas-exotoxin fusion protein and vb4-845.